EYE CANCER
Clinical trials for EYE CANCER explained in plain language.
Never miss a new study
Get alerted when new EYE CANCER trials appear
Sign up with your email to follow new studies for EYE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot for eye tumors shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called belzupacap sarotalocan (AU-011) for people whose cancer has spread to the back of the eye (the choroid). The drug is given as an injection near the eye. The main goals are to check safety and see if it shrinks the tumor. About 24 adults with thi…
Matched conditions: EYE CANCER
Phase: PHASE2 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 17, 2026 06:48 UTC
-
New pill shows promise for rare eye cancer that spreads
Disease control Recruiting nowThis study tests an experimental drug called NBM-BMX for people with metastatic uveal melanoma, a rare eye cancer that has spread to other parts of the body. The goal is to find the best dose, check for side effects, and see if the drug can shrink tumors or slow the cancer. About…
Matched conditions: EYE CANCER
Phase: PHASE1, PHASE2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated May 01, 2026 15:59 UTC